M&A Deal Summary

Avista Healthcare Partners and The Carlyle Group Acquire BioReliance

On April 12, 2007, private equity firms Avista Healthcare Partners and The Carlyle Group acquired healthcare services company BioReliance from Invitrogen for 210M USD

Acquisition Highlights
  • This is Avista Healthcare Partners’ 1st and The Carlyle Group’s 5th transaction in the Healthcare Services sector.
  • This is Avista Healthcare Partners’ 9th and The Carlyle Group’s 109th largest (disclosed) transaction.
  • This is Avista Healthcare Partners’ 9th and The Carlyle Group’s 163rd transaction in the United States.
  • This is Avista Healthcare Partners’ 1st and The Carlyle Group’s 9th transaction in Maryland.
Investment Fate
  • BioReliance was sold to a publicly-traded strategic buyer in 2012 for 350M USD.

M&A Deal Summary
Date 2007-04-12
Target BioReliance
Sector Healthcare Services
Buyer(s) Avista Healthcare Partners
The Carlyle Group
Sellers(s) Invitrogen
Deal Type Divestiture
Deal Value 210M USD

Target

BioReliance

Rockville, Maryland, United States
BioReliance provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Avista Healthcare Partners

New York, New York, United States
Category Private Equity Firm
Founded 2005
PE ASSETS 8.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 11 of 54
Sector (Healthcare Services) 1 of 4
Type (Divestiture) 1 of 8
State (Maryland) 1 of 3
Country (United States) 9 of 43
Year (2007) 1 of 4
Size (of disclosed) 9 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Peregrine Oil & Gas I

Houston, Texas, United States

Peregrine is a Houston Texas based independent oil and gas acquisition and development company formed for the purpose of pursuing a growth strategy concentrated on the acquisition and further development of under-managed and under-exploited oil and gas properties located principally in the offshore Gulf of Mexico region.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-02 VWR International

Radnor, Pennsylvania, United States

VWR International LLC is a distributor of products, services and solutions to laboratory and production facilities. VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries.

Buy -
Buyer

The Carlyle Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1987
PE ASSETS 435.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.

The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.

DEAL STATS #
Overall 274 of 744
Sector (Healthcare Services) 5 of 28
Type (Divestiture) 27 of 72
State (Maryland) 9 of 10
Country (United States) 163 of 349
Year (2007) 14 of 52
Size (of disclosed) 109 of 137
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-03-29 Yangzhou Chengde Steel Tube

Jiangsu, China

Yangzhou Chengde Steel Tube Co. Ltd. is a manufacturer of large diameter seamless steel pipes.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-18 Nakaya Microdevices

Oita, Japan

Nakaya Microdevices Ltd. is one of Japan's top independent outsourced semiconductor assembly and testing service providers.

Buy -

Seller(S) 1

SELLER

Invitrogen

Carlsbad, California, United States
Category Company
Sector Life Science
DESCRIPTION

Invitrogen Corp. develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities.

DEAL STATS #
Overall 1 of 2
Sector (Healthcare Services) 1 of 1
Type (Divestiture) 1 of 2
State (Maryland) 1 of 1
Country (United States) 1 of 2
Year (2007) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-01 Sentigen Holding

Phillipsburg, New Jersey, United States

Sentigen Holding Corp. is a provider of contract research and development services to the biotechnology and pharmaceutical industries

Buy $26M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-11 CellzDirect

Durham, North Carolina, United States

CellzDirect, Inc. is a bioscience company.

Buy $57M
Mergr

Product

Company

Legal